National pharmaceutical distributor serving Canadian pharmacies and hospitals
Kohl & Frisch is a Concord-based pharmaceutical wholesaler whose back office runs almost entirely on Microsoft: Dynamics 365 Finance and Operations, Power Platform, Fabric and Azure DevOps, with legacy AS/400 still in the mix. Hiring is accelerating and tilts toward finance, sales and narcotics control, matching pain points around controlled-substance compliance and winning share among independent pharmacies.
Kohl & Frisch Limited is a privately held healthcare distributor founded in 1916 and headquartered in Concord, Ontario. It sits between pharmaceutical manufacturers and healthcare providers, supplying prescription, over-the-counter, home healthcare and front-shop products. Customers include chain retailers, independent pharmacies, clinics and hospitals. The company operates distribution centres in Vancouver, Calgary, Regina, Winnipeg, Toronto, Montreal and Moncton, and employs 201-500 people.
Kohl & Frisch runs Microsoft Dynamics 365 (Finance and Operations, Sales, Customer Service), Power Platform, Azure, Microsoft Fabric and Power BI, alongside Salesforce, Shopify, SQL Server, M-Files and AS/400.
Kohl & Frisch is headquartered in Concord, Ontario, with distribution centres in Vancouver, Calgary, Regina, Winnipeg, Toronto, Montreal and Moncton.
Current initiatives include its Health One private label program, the healthsnap.ca e-commerce site, pharmacy flyer and retail customer programs, independent pharmacy recruitment, and health and safety audits of distribution centres.
Other companies in the same industry, closest in size
Kohl & Frisch Limited's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.